The United States will begin participating in an international collaboration to distribute COVID-19 vaccines more equitably around the world after President Joe Biden reversed the Trump administration’s withdrawal from the World Health Organization on his first day in office. Richard Marlink, the director of Rutgers Global Health Institute, discusses the impact COVAX, the global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, will have on ending the COVID-19 pandemic and strengthening global health. To read the full story.
Recent Posts
- Join NJ ACTS for a Seminar on Clinical Research Record Retention on 3/2 at 12
- CTSA Translational Impact Summit on March 2&3 (Virtual) – Register Now!
- Join NJ ACTS for Boosted: The Impact of Science, Society, and Policy on Public Health on 2/27 at 12
- NJACTS Community Engagement Core COVID-19 Resources
- Join NJ ACTS on 2/12 at 4pm for the Pilots Program 2026 Webinar
Categories
- Community (2,439)
- Covid (997)
- CTO Events (6)
- News (3,091)
- Pilots (21)